Article
Impact of transmission intensity on the accuracy of genotyping to distinguish recrudescence from new infection in antimalarial clinical trials.
Antimicrobial agents and chemotherapy - 1 Sept 2007
Greenhouse Bryan, Dokomajilar Christian, Hubbard Alan, Rosenthal Philip J, Dorsey Grant
Abstract excerpt
Antimalarial clinical trials use genotyping techniques to distinguish new infection from recrudescence. In areas of high transmission, the accuracy of genotyping may be compromised due to the high number of infecting parasite strains. We compared the accuracies of genotyping methods, using up to six genotyping markers, to assign outcomes for two large antimalarial trials performed in areas of Africa with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
